カテゴリ： 世界, 医療/バイオ, QYResearch

血漿分画の世界市場2023年：免疫グロブリン、凝固因子、アルブミン、その他

■ 英語タイトル：Global Blood Plasma Fractionation Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7675）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7675
■ 発行日：2023年3月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：103
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥429,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥643,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥858,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[血漿分画の世界市場2023年：免疫グロブリン、凝固因子、アルブミン、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は血漿分画のグローバル市場について調査・分析し、世界の血漿分画市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（免疫グロブリン、凝固因子、アルブミン、その他）、用途別セグメント分析（病院、薬局、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Takeda、CSL、Grifols、Octapharma、Kedrion、LFB Group、Biotest、BPL、RAAS、CBPO、Hualan Bio、Tiantan Bio、Shuanglin Bio、Boya Bio、Yuanda Shuyang、Weiguang Bio、Nanyue Bio、KM Biologicsなどが含まれています。血漿分画のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、血漿分画市場規模を算出する際に考慮しました。

・血漿分画市場の概要
- 製品の定義
- 血漿分画の種類別セグメント
- 世界の血漿分画市場規模：タイプ別分析（免疫グロブリン、凝固因子、アルブミン、その他）
- 血漿分画の用途別セグメント
- 世界の血漿分画市場規模：用途別分析（病院、薬局、その他）
- 世界の血漿分画市場規模予測（2018年-2029年）
- 血漿分画の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 血漿分画市場の競争状況およびトレンド

・血漿分画の地域別市場規模
- 北米の血漿分画市場規模（2018年-2029年）
- 米国の血漿分画市場規模（2018年-2029年）
- ヨーロッパの血漿分画市場規模（2018年-2029年）
- アジア太平洋の血漿分画市場規模（2018年-2029年）
- 中国の血漿分画市場規模（2018年-2029年）
- 日本の血漿分画市場規模（2018年-2029年）
- 韓国の血漿分画市場規模（2018年-2029年）
- インドの血漿分画市場規模（2018年-2029年）
- オーストラリアの血漿分画市場規模（2018年-2029年）
- 中南米の血漿分画市場規模（2018年-2029年）
- 中東・アフリカの血漿分画市場規模（2018年-2029年）

・種類別セグメント：免疫グロブリン、凝固因子、アルブミン、その他
- 世界の血漿分画のタイプ別販売量（2018年-2023年）
- 世界の血漿分画のタイプ別売上（2018年-2023年）
- 世界の血漿分画のタイプ別価格

・用途別セグメント：病院、薬局、その他
- 世界の血漿分画の用途別販売量（2018年-2023年）
- 世界の血漿分画の用途別売上（2018年-2023年）
- 世界の血漿分画の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Takeda、CSL、Grifols、Octapharma、Kedrion、LFB Group、Biotest、BPL、RAAS、CBPO、Hualan Bio、Tiantan Bio、Shuanglin Bio、Boya Bio、Yuanda Shuyang、Weiguang Bio、Nanyue Bio、KM Biologics

・産業チェーンと販売チャネルの分析
- 血漿分画産業チェーン分析
- 血漿分画の主要原材料
- 血漿分画の販売チャネル
- 血漿分画のディストリビューター
- 血漿分画の主要顧客

・血漿分画市場ダイナミクス
- 血漿分画の業界動向
- 血漿分画市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Human blood plasma is nature’s raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation.
Highlights
The global Blood Plasma Fractionation market was valued at US$ 28320 million in 2022 and is anticipated to reach US$ 47160 million by 2029, witnessing a CAGR of 7.6% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global key blood plasma fractionation players include CSL, Grifols and Takeda etc. The top 3 companies hold a share about 55%. North America is the largest market with a share about 40%, followed by Asia-Pacific and Europe.
In terms of product, Immune Globulin is the largest segment with a share about 50%. And in terms of applications, the largest application is hospital with a share about 70%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Blood Plasma Fractionation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma Fractionation.
The Blood Plasma Fractionation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Blood Plasma Fractionation market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Plasma Fractionation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Segment by Type
Immune Globulin
Coagulation Factor
Albumin
Other
Segment by Application
Hospital
Retail Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Blood Plasma Fractionation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Blood Plasma Fractionation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Blood Plasma Fractionation market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Plasma Fractionation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Blood Plasma Fractionation and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Blood Plasma Fractionation industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Plasma Fractionation.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Blood Plasma Fractionation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Blood Plasma Fractionation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Blood Plasma Fractionation Market Overview
1.1 Product Overview and Scope of Blood Plasma Fractionation
1.2 Blood Plasma Fractionation Segment by Type
1.2.1 Global Blood Plasma Fractionation Market Value Comparison by Type (2023-2029)
1.2.2 Immune Globulin
1.2.3 Coagulation Factor
1.2.4 Albumin
1.2.5 Other
1.3 Blood Plasma Fractionation Segment by Application
1.3.1 Global Blood Plasma Fractionation Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Global Blood Plasma Fractionation Market Size Estimates and Forecasts
1.4.1 Global Blood Plasma Fractionation Revenue 2018-2029
1.4.2 Global Blood Plasma Fractionation Sales 2018-2029
1.4.3 Global Blood Plasma Fractionation Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Blood Plasma Fractionation Market Competition by Manufacturers
2.1 Global Blood Plasma Fractionation Sales Market Share by Manufacturers (2018-2023)
2.2 Global Blood Plasma Fractionation Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Blood Plasma Fractionation Average Price by Manufacturers (2018-2023)
2.4 Global Blood Plasma Fractionation Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Blood Plasma Fractionation, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Blood Plasma Fractionation, Product Type & Application
2.7 Blood Plasma Fractionation Market Competitive Situation and Trends
2.7.1 Blood Plasma Fractionation Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Blood Plasma Fractionation Players Market Share by Revenue
2.7.3 Global Blood Plasma Fractionation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Blood Plasma Fractionation Retrospective Market Scenario by Region
3.1 Global Blood Plasma Fractionation Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Blood Plasma Fractionation Global Blood Plasma Fractionation Sales by Region: 2018-2029
3.2.1 Global Blood Plasma Fractionation Sales by Region: 2018-2023
3.2.2 Global Blood Plasma Fractionation Sales by Region: 2024-2029
3.3 Global Blood Plasma Fractionation Global Blood Plasma Fractionation Revenue by Region: 2018-2029
3.3.1 Global Blood Plasma Fractionation Revenue by Region: 2018-2023
3.3.2 Global Blood Plasma Fractionation Revenue by Region: 2024-2029
3.4 North America Blood Plasma Fractionation Market Facts & Figures by Country
3.4.1 North America Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Blood Plasma Fractionation Sales by Country (2018-2029)
3.4.3 North America Blood Plasma Fractionation Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Blood Plasma Fractionation Market Facts & Figures by Country
3.5.1 Europe Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Blood Plasma Fractionation Sales by Country (2018-2029)
3.5.3 Europe Blood Plasma Fractionation Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Blood Plasma Fractionation Market Facts & Figures by Country
3.6.1 Asia Pacific Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Blood Plasma Fractionation Sales by Country (2018-2029)
3.6.3 Asia Pacific Blood Plasma Fractionation Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Blood Plasma Fractionation Market Facts & Figures by Country
3.7.1 Latin America Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Blood Plasma Fractionation Sales by Country (2018-2029)
3.7.3 Latin America Blood Plasma Fractionation Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Blood Plasma Fractionation Market Facts & Figures by Country
3.8.1 Middle East and Africa Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Blood Plasma Fractionation Sales by Country (2018-2029)
3.8.3 Middle East and Africa Blood Plasma Fractionation Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Blood Plasma Fractionation Sales by Type (2018-2029)
4.1.1 Global Blood Plasma Fractionation Sales by Type (2018-2023)
4.1.2 Global Blood Plasma Fractionation Sales by Type (2024-2029)
4.1.3 Global Blood Plasma Fractionation Sales Market Share by Type (2018-2029)
4.2 Global Blood Plasma Fractionation Revenue by Type (2018-2029)
4.2.1 Global Blood Plasma Fractionation Revenue by Type (2018-2023)
4.2.2 Global Blood Plasma Fractionation Revenue by Type (2024-2029)
4.2.3 Global Blood Plasma Fractionation Revenue Market Share by Type (2018-2029)
4.3 Global Blood Plasma Fractionation Price by Type (2018-2029)
5 Segment by Application
5.1 Global Blood Plasma Fractionation Sales by Application (2018-2029)
5.1.1 Global Blood Plasma Fractionation Sales by Application (2018-2023)
5.1.2 Global Blood Plasma Fractionation Sales by Application (2024-2029)
5.1.3 Global Blood Plasma Fractionation Sales Market Share by Application (2018-2029)
5.2 Global Blood Plasma Fractionation Revenue by Application (2018-2029)
5.2.1 Global Blood Plasma Fractionation Revenue by Application (2018-2023)
5.2.2 Global Blood Plasma Fractionation Revenue by Application (2024-2029)
5.2.3 Global Blood Plasma Fractionation Revenue Market Share by Application (2018-2029)
5.3 Global Blood Plasma Fractionation Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Takeda Blood Plasma Fractionation Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CSL Blood Plasma Fractionation Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Grifols Blood Plasma Fractionation Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Octapharma Blood Plasma Fractionation Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Kedrion
6.5.1 Kedrion Corporation Information
6.5.2 Kedrion Description and Business Overview
6.5.3 Kedrion Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Kedrion Blood Plasma Fractionation Product Portfolio
6.5.5 Kedrion Recent Developments/Updates
6.6 LFB Group
6.6.1 LFB Group Corporation Information
6.6.2 LFB Group Description and Business Overview
6.6.3 LFB Group Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.6.4 LFB Group Blood Plasma Fractionation Product Portfolio
6.6.5 LFB Group Recent Developments/Updates
6.7 Biotest
6.6.1 Biotest Corporation Information
6.6.2 Biotest Description and Business Overview
6.6.3 Biotest Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biotest Blood Plasma Fractionation Product Portfolio
6.7.5 Biotest Recent Developments/Updates
6.8 BPL
6.8.1 BPL Corporation Information
6.8.2 BPL Description and Business Overview
6.8.3 BPL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.8.4 BPL Blood Plasma Fractionation Product Portfolio
6.8.5 BPL Recent Developments/Updates
6.9 RAAS
6.9.1 RAAS Corporation Information
6.9.2 RAAS Description and Business Overview
6.9.3 RAAS Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.9.4 RAAS Blood Plasma Fractionation Product Portfolio
6.9.5 RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Corporation Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.10.4 CBPO Blood Plasma Fractionation Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 Hualan Bio
6.11.1 Hualan Bio Corporation Information
6.11.2 Hualan Bio Blood Plasma Fractionation Description and Business Overview
6.11.3 Hualan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Hualan Bio Blood Plasma Fractionation Product Portfolio
6.11.5 Hualan Bio Recent Developments/Updates
6.12 Tiantan Bio
6.12.1 Tiantan Bio Corporation Information
6.12.2 Tiantan Bio Blood Plasma Fractionation Description and Business Overview
6.12.3 Tiantan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Tiantan Bio Blood Plasma Fractionation Product Portfolio
6.12.5 Tiantan Bio Recent Developments/Updates
6.13 Shuanglin Bio
6.13.1 Shuanglin Bio Corporation Information
6.13.2 Shuanglin Bio Blood Plasma Fractionation Description and Business Overview
6.13.3 Shuanglin Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Shuanglin Bio Blood Plasma Fractionation Product Portfolio
6.13.5 Shuanglin Bio Recent Developments/Updates
6.14 Boya Bio
6.14.1 Boya Bio Corporation Information
6.14.2 Boya Bio Blood Plasma Fractionation Description and Business Overview
6.14.3 Boya Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Boya Bio Blood Plasma Fractionation Product Portfolio
6.14.5 Boya Bio Recent Developments/Updates
6.15 Yuanda Shuyang
6.15.1 Yuanda Shuyang Corporation Information
6.15.2 Yuanda Shuyang Blood Plasma Fractionation Description and Business Overview
6.15.3 Yuanda Shuyang Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Yuanda Shuyang Blood Plasma Fractionation Product Portfolio
6.15.5 Yuanda Shuyang Recent Developments/Updates
6.16 Weiguang Bio
6.16.1 Weiguang Bio Corporation Information
6.16.2 Weiguang Bio Blood Plasma Fractionation Description and Business Overview
6.16.3 Weiguang Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Weiguang Bio Blood Plasma Fractionation Product Portfolio
6.16.5 Weiguang Bio Recent Developments/Updates
6.17 Nanyue Bio
6.17.1 Nanyue Bio Corporation Information
6.17.2 Nanyue Bio Blood Plasma Fractionation Description and Business Overview
6.17.3 Nanyue Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Nanyue Bio Blood Plasma Fractionation Product Portfolio
6.17.5 Nanyue Bio Recent Developments/Updates
6.18 KM Biologics
6.18.1 KM Biologics Corporation Information
6.18.2 KM Biologics Blood Plasma Fractionation Description and Business Overview
6.18.3 KM Biologics Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.18.4 KM Biologics Blood Plasma Fractionation Product Portfolio
6.18.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Blood Plasma Fractionation Industry Chain Analysis
7.2 Blood Plasma Fractionation Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Blood Plasma Fractionation Production Mode & Process
7.4 Blood Plasma Fractionation Sales and Marketing
7.4.1 Blood Plasma Fractionation Sales Channels
7.4.2 Blood Plasma Fractionation Distributors
7.5 Blood Plasma Fractionation Customers
8 Blood Plasma Fractionation Market Dynamics
8.1 Blood Plasma Fractionation Industry Trends
8.2 Blood Plasma Fractionation Market Drivers
8.3 Blood Plasma Fractionation Market Challenges
8.4 Blood Plasma Fractionation Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Blood Plasma Fractionation Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Blood Plasma Fractionation Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Blood Plasma Fractionation Market Competitive Situation by Manufacturers in 2022
Table 4. Global Blood Plasma Fractionation Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Blood Plasma Fractionation Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Blood Plasma Fractionation Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Blood Plasma Fractionation Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Blood Plasma Fractionation Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Blood Plasma Fractionation, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Blood Plasma Fractionation, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Blood Plasma Fractionation, Product Type & Application
Table 12. Global Key Manufacturers of Blood Plasma Fractionation, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Blood Plasma Fractionation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Fractionation as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Blood Plasma Fractionation Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Blood Plasma Fractionation Sales by Region (2018-2023) & (K Units)
Table 18. Global Blood Plasma Fractionation Sales Market Share by Region (2018-2023)
Table 19. Global Blood Plasma Fractionation Sales by Region (2024-2029) & (K Units)
Table 20. Global Blood Plasma Fractionation Sales Market Share by Region (2024-2029)
Table 21. Global Blood Plasma Fractionation Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Blood Plasma Fractionation Revenue Market Share by Region (2018-2023)
Table 23. Global Blood Plasma Fractionation Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Blood Plasma Fractionation Revenue Market Share by Region (2024-2029)
Table 25. North America Blood Plasma Fractionation Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Blood Plasma Fractionation Sales by Country (2018-2023) & (K Units)
Table 27. North America Blood Plasma Fractionation Sales by Country (2024-2029) & (K Units)
Table 28. North America Blood Plasma Fractionation Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Blood Plasma Fractionation Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Blood Plasma Fractionation Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Blood Plasma Fractionation Sales by Country (2018-2023) & (K Units)
Table 32. Europe Blood Plasma Fractionation Sales by Country (2024-2029) & (K Units)
Table 33. Europe Blood Plasma Fractionation Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Blood Plasma Fractionation Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Blood Plasma Fractionation Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Blood Plasma Fractionation Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Blood Plasma Fractionation Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Blood Plasma Fractionation Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Blood Plasma Fractionation Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Blood Plasma Fractionation Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Blood Plasma Fractionation Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Blood Plasma Fractionation Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Blood Plasma Fractionation Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Blood Plasma Fractionation Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Blood Plasma Fractionation Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Blood Plasma Fractionation Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Blood Plasma Fractionation Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Blood Plasma Fractionation Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Blood Plasma Fractionation Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Blood Plasma Fractionation Sales (K Units) by Type (2018-2023)
Table 51. Global Blood Plasma Fractionation Sales (K Units) by Type (2024-2029)
Table 52. Global Blood Plasma Fractionation Sales Market Share by Type (2018-2023)
Table 53. Global Blood Plasma Fractionation Sales Market Share by Type (2024-2029)
Table 54. Global Blood Plasma Fractionation Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Blood Plasma Fractionation Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Blood Plasma Fractionation Revenue Market Share by Type (2018-2023)
Table 57. Global Blood Plasma Fractionation Revenue Market Share by Type (2024-2029)
Table 58. Global Blood Plasma Fractionation Price (US$/Unit) by Type (2018-2023)
Table 59. Global Blood Plasma Fractionation Price (US$/Unit) by Type (2024-2029)
Table 60. Global Blood Plasma Fractionation Sales (K Units) by Application (2018-2023)
Table 61. Global Blood Plasma Fractionation Sales (K Units) by Application (2024-2029)
Table 62. Global Blood Plasma Fractionation Sales Market Share by Application (2018-2023)
Table 63. Global Blood Plasma Fractionation Sales Market Share by Application (2024-2029)
Table 64. Global Blood Plasma Fractionation Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Blood Plasma Fractionation Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Blood Plasma Fractionation Revenue Market Share by Application (2018-2023)
Table 67. Global Blood Plasma Fractionation Revenue Market Share by Application (2024-2029)
Table 68. Global Blood Plasma Fractionation Price (US$/Unit) by Application (2018-2023)
Table 69. Global Blood Plasma Fractionation Price (US$/Unit) by Application (2024-2029)
Table 70. Takeda Corporation Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Takeda Blood Plasma Fractionation Product
Table 74. Takeda Recent Developments/Updates
Table 75. CSL Corporation Information
Table 76. CSL Description and Business Overview
Table 77. CSL Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. CSL Blood Plasma Fractionation Product
Table 79. CSL Recent Developments/Updates
Table 80. Grifols Corporation Information
Table 81. Grifols Description and Business Overview
Table 82. Grifols Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Grifols Blood Plasma Fractionation Product
Table 84. Grifols Recent Developments/Updates
Table 85. Octapharma Corporation Information
Table 86. Octapharma Description and Business Overview
Table 87. Octapharma Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Octapharma Blood Plasma Fractionation Product
Table 89. Octapharma Recent Developments/Updates
Table 90. Kedrion Corporation Information
Table 91. Kedrion Description and Business Overview
Table 92. Kedrion Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Kedrion Blood Plasma Fractionation Product
Table 94. Kedrion Recent Developments/Updates
Table 95. LFB Group Corporation Information
Table 96. LFB Group Description and Business Overview
Table 97. LFB Group Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. LFB Group Blood Plasma Fractionation Product
Table 99. LFB Group Recent Developments/Updates
Table 100. Biotest Corporation Information
Table 101. Biotest Description and Business Overview
Table 102. Biotest Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Biotest Blood Plasma Fractionation Product
Table 104. Biotest Recent Developments/Updates
Table 105. BPL Corporation Information
Table 106. BPL Description and Business Overview
Table 107. BPL Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. BPL Blood Plasma Fractionation Product
Table 109. BPL Recent Developments/Updates
Table 110. RAAS Corporation Information
Table 111. RAAS Description and Business Overview
Table 112. RAAS Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. RAAS Blood Plasma Fractionation Product
Table 114. RAAS Recent Developments/Updates
Table 115. CBPO Corporation Information
Table 116. CBPO Description and Business Overview
Table 117. CBPO Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. CBPO Blood Plasma Fractionation Product
Table 119. CBPO Recent Developments/Updates
Table 120. Hualan Bio Corporation Information
Table 121. Hualan Bio Description and Business Overview
Table 122. Hualan Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Hualan Bio Blood Plasma Fractionation Product
Table 124. Hualan Bio Recent Developments/Updates
Table 125. Tiantan Bio Corporation Information
Table 126. Tiantan Bio Description and Business Overview
Table 127. Tiantan Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Tiantan Bio Blood Plasma Fractionation Product
Table 129. Tiantan Bio Recent Developments/Updates
Table 130. Shuanglin Bio Corporation Information
Table 131. Shuanglin Bio Description and Business Overview
Table 132. Shuanglin Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Shuanglin Bio Blood Plasma Fractionation Product
Table 134. Shuanglin Bio Recent Developments/Updates
Table 135. Boya Bio Corporation Information
Table 136. Boya Bio Description and Business Overview
Table 137. Boya Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Boya Bio Blood Plasma Fractionation Product
Table 139. Boya Bio Recent Developments/Updates
Table 140. Yuanda Shuyang Corporation Information
Table 141. Yuanda Shuyang Description and Business Overview
Table 142. Yuanda Shuyang Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Yuanda Shuyang Blood Plasma Fractionation Product
Table 144. Yuanda Shuyang Recent Developments/Updates
Table 145. Weiguang Bio Corporation Information
Table 146. Weiguang Bio Description and Business Overview
Table 147. Weiguang Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Weiguang Bio Blood Plasma Fractionation Product
Table 149. Weiguang Bio Recent Developments/Updates
Table 150. Nanyue Bio Corporation Information
Table 151. Nanyue Bio Description and Business Overview
Table 152. Nanyue Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Nanyue Bio Blood Plasma Fractionation Product
Table 154. Nanyue Bio Recent Developments/Updates
Table 155. KM Biologics Corporation Information
Table 156. KM Biologics Description and Business Overview
Table 157. KM Biologics Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. KM Biologics Blood Plasma Fractionation Product
Table 159. KM Biologics Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Blood Plasma Fractionation Distributors List
Table 163. Blood Plasma Fractionation Customers List
Table 164. Blood Plasma Fractionation Market Trends
Table 165. Blood Plasma Fractionation Market Drivers
Table 166. Blood Plasma Fractionation Market Challenges
Table 167. Blood Plasma Fractionation Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Blood Plasma Fractionation
Figure 2. Global Blood Plasma Fractionation Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Blood Plasma Fractionation Market Share by Type in 2022 & 2029
Figure 4. Immune Globulin Product Picture
Figure 5. Coagulation Factor Product Picture
Figure 6. Albumin Product Picture
Figure 7. Other Product Picture
Figure 8. Global Blood Plasma Fractionation Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Blood Plasma Fractionation Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Retail Pharmacy
Figure 12. Other
Figure 13. Global Blood Plasma Fractionation Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Blood Plasma Fractionation Market Size (2018-2029) & (US$ Million)
Figure 15. Global Blood Plasma Fractionation Sales (2018-2029) & (K Units)
Figure 16. Global Blood Plasma Fractionation Average Price (US$/Unit) & (2018-2029)
Figure 17. Blood Plasma Fractionation Report Years Considered
Figure 18. Blood Plasma Fractionation Sales Share by Manufacturers in 2022
Figure 19. Global Blood Plasma Fractionation Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Blood Plasma Fractionation Players: Market Share by Revenue in 2022
Figure 21. Blood Plasma Fractionation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Blood Plasma Fractionation Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Blood Plasma Fractionation Sales Market Share by Country (2018-2029)
Figure 24. North America Blood Plasma Fractionation Revenue Market Share by Country (2018-2029)
Figure 25. United States Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Blood Plasma Fractionation Sales Market Share by Country (2018-2029)
Figure 28. Europe Blood Plasma Fractionation Revenue Market Share by Country (2018-2029)
Figure 29. Germany Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Blood Plasma Fractionation Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Blood Plasma Fractionation Revenue Market Share by Region (2018-2029)
Figure 36. China Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Blood Plasma Fractionation Sales Market Share by Country (2018-2029)
Figure 46. Latin America Blood Plasma Fractionation Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Blood Plasma Fractionation Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Blood Plasma Fractionation Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Blood Plasma Fractionation by Type (2018-2029)
Figure 56. Global Revenue Market Share of Blood Plasma Fractionation by Type (2018-2029)
Figure 57. Global Blood Plasma Fractionation Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Blood Plasma Fractionation by Application (2018-2029)
Figure 59. Global Revenue Market Share of Blood Plasma Fractionation by Application (2018-2029)
Figure 60. Global Blood Plasma Fractionation Price (US$/Unit) by Application (2018-2029)
Figure 61. Blood Plasma Fractionation Value Chain
Figure 62. Blood Plasma Fractionation Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 血漿分画技術の世界市場2023年：アルブミン、免疫グロブリン、凝固因子、その他
  • 血漿分画技術のグローバル市場展望 2023年-2029年：アルブミン、免疫グロブリン、凝固因子、その他
  • ヒト血漿分画のグローバル市場展望 2023年-2029年：免疫グロブリン、凝固因子、アルブミン、その他
  • 血漿タンパク質製品のグローバル市場展望 2023年-2029年：アルブミン、免疫グロブリン、凝固因子、その他
  • 血漿由来医療製品のグローバル市場展望 2023年-2029年：免疫グロブリン、凝固因子、アルブミン、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7675 )"血漿分画の世界市場2023年：免疫グロブリン、凝固因子、アルブミン、その他" (英文：Global Blood Plasma Fractionation Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。